This site is intended for Healthcare Professionals only.

Workforce issues, staff retention remain a big concern for LPCs

Date:

Share post:

Workforce issues, staff retention and capacity continues to be a big concern for the Local Pharmaceutical Committee as it discussed the topics at a recent meeting with the Pharmaceutical Services Negotiating Committee (PSNC).

The meeting, attended by delegates from 66 LPCs, focused on the current challenges faced by community pharmacies as well as the planning for the next year.

Around 64 per cent of delegates said workforce was the top challenge faced by pharmacy contractors, and suggested reducing the migration of pharmacists to Primary Care Networks (PCNs).

Other suggestions included – “improving the development opportunities available for pharmacists and their teams, and rebranding the profession to make community pharmacy a more attractive route for young graduates.”

On the development of Integrated Care Systems (ICS), the majority of respondents were positive about their LPC’s engagement in the new setting.

Most of the delegates agreed “with mapping the future LPC network around ICS, given their growing importance in the healthcare landscape.”

PSNC will use the outcome of these polls to prioritize its workstreams for the coming months.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

DHSC Plans to Allow Hub and Spoke Models Across Different Pharmacy Ownerships Soon

It has decided to proceed with the implementation of the two hub and spoke models that it consulted...

NHS Long Term Workforce Plan: 350 more medical school places allocated

The Office for Students (OfS) has targeted under-doctored areas in its allocation of the medical school places The government has...

Continuing royal legacy: RPS appoints King Charles as new patron

King Charles's patronage signals a new era of support for the RPS's mission to advance healthcare and patient-well...

Cipla, Glenmark recall products from US market due to manufacturing issues

Cipla USA is recalling 59,244 packs of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution   Two Indian pharmaceutical companies,...